Background: Matrix metalloprotease-9 (MMP-9) plays an important role in the
degradation of extracellular matrix (ECM). In cholesteatoma there are sign
ificant changes in the composition of the ECM, supporting the view of a dis
turbed cell-ECM interaction. it has been reported that in cholesteatoma tis
sues, MMP-9 is: expressed in epithelial cells but not in stromal cells. In
this study, we report conflicting results regarding the identity of the cho
lesteatoma cells that express MMP-9.
Methods: An immunohistochemical assay was performed to examine the expressi
on of MMP-9 in 35 cases (formalin-fixed paraffin-embedded sections) of chol
esteatoma. using an MMP-9-specific monoclonal antibody.
Results: In all cholesteatomas examined, MMP-9 was expressed in the stromal
cells hut not in the epithelial cells. MMP-9 immunostaining was undetectab
le in external auditory meatal skin (n = 5) and tympanic membrane (n = 3).
Conclusions: These results suggest that the MMP-9 expressed in stromal cell
s may be involved in the disturbed cell-ECM interaction associated with the
process of cholesteatoma formation.